| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +240,804 | 100% | $3.18 | +$765,977 |
| Sells | 0 | ||||
| Net | +5 | +240,804 | 100% | +$765,977 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| MANNER CARRIE EGLINTON | President & CEO, Director | $5,309,398 | +$347,405 | +7% | 04 Jun 2025 |
| STEPHEN S. TANG PHD | President and CEO | $2,863,231 | 01 Feb 2022 | ||
| Kathleen Gallagher Weber | Chief Product Officer | $1,419,100 | 01 Mar 2025 | ||
| Kenneth J. McGrath | Chief Financial Officer | $1,246,727 | +$201,683 | +19% | 08 Aug 2025 |
| JACK E. JERRETT | SVP General Counsel & CCO | $1,019,545 | 31 Dec 2021 | ||
| Lisa Nibauer | President of Diagnostics | $1,010,737 | 11 May 2022 | ||
| Roberto Cuca | Cfo | $939,818 | 07 May 2021 | ||
| Michael Celano | Director | $915,327 | 12 Aug 2022 | ||
| RONNY B. LANCASTER | Director | $857,693 | 26 Aug 2022 | ||
| Scott Gleason | Interim CFO/SVP IR | $789,974 | 21 May 2022 | ||
| Agnieszka Gallagher | General Counsel & CCO | $741,475 | 01 Feb 2022 | ||
| Mara G. Aspinall | Director | $602,414 | 13 May 2025 | ||
| Michele Anthony | SVP Finance & CAO | $520,554 | 01 Mar 2025 | ||
| EAMONN P. HOBBS | Director | $503,015 | 16 May 2022 | ||
| Lelio Marmora | Director | $440,661 | +$21,420 | +5.1% | 13 May 2025 |
| James A. Datin | Director | $432,499 | 14 May 2024 | ||
| David Shulkin | Director | $425,748 | 13 May 2025 | ||
| John P. Kenny | Director | $402,475 | +$151,217 | +60% | 17 Dec 2025 |
| Nancy J. Gagliano | Director | $380,170 | +$44,252 | +13% | 28 Nov 2025 |
| Robert W. McMahon | Director | $320,240 | 31 Jul 2025 | ||
| Anne Clem Whitaker | Director | $195,142 | 15 May 2023 | ||
| Steven Kyle Boyd | Director | $105,973 | 28 Oct 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|